Hodgen; Gary D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hodgen; Gary D..The latest application filed is for "hormone replacement therapy".

Company Profile

0.18.4

Hodgen; Gary D. - Norfolk VA
Hodgen; Gary D. - Virginia Beach VA
Hodgen; Gary D. - Potomac MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception Grant 7,704,983 - Hodgen , et al. April 27, 2	2010-04-27
Antiprogestin method and kit for reducing side effects associated with low dosage HRT, oral contraception and regulating menses Grant 7,538,099 - Hodgen , et al. May 26, 2	2009-05-26
Adjunctive therapy Grant RE40,119 - Hodgen February 26, 2	2008-02-26
Methods of extended use oral contraception Grant RE39,861 - Hodgen September 25, 2	2007-09-25
Control of selective estrogen receptor modulators Grant 7,256,185 - Hodgen August 14, 2	2007-08-14
Hormone replacement therapy App 20060014728 - Chwalisz; Kristof ; et al.	2006-01-19
Control of selective estrogen receptor modulators Grant 6,653,297 - Hodgen November 25, 2	2003-11-25
Control Of Selective Estrogen Receptor Modulators App 20030181431 - HODGEN, GARY D.	2003-09-25
Ultra low dose oral contraceptives with sustained efficacy and induced amenorrhea App 20030018018 - Hodgen, Gary D. ; et al.	2003-01-23
Derivation Of Cells And Tissues From Embryonic Pre-stem Cells For Transplantation Therapies App 20020159975 - HODGEN, GARY D.	2002-10-31
Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy Grant 5,898,032 - Hodgen April 27, 1	1999-04-27
Adjunctive therapy Grant 5,691,314 - Hodgen November 25, 1	1997-11-25
Treatment of ovarian estrogen dependent conditions Grant 5,681,817 - Hodgen , et al. October 28, 1	1997-10-28
Minimizing progestin associated breakthrough bleeding Grant 5,622,943 - Hodgen April 22, 1	1997-04-22
Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy Grant 5,552,394 - Hodgen September 3, 1	1996-09-03
Fertility assay Grant 5,219,729 - Hodgen June 15, 1	1993-06-15
Combined treatment with GnRH antagonist and GnRH to control gonadotropin levels in mammals Grant 5,180,711 - Hodgen January 19, 1	1993-01-19
Method and kit for contraception with GnRH-antagonist Grant 5,116,818 - Hodgen , et al. May 26, 1	1992-05-26
Method of inducing ovulation Grant 4,845,077 - Hodgen July 4, 1	1989-07-04
Predicting predisposition to osteoporosis Grant 4,740,364 - Hodgen April 26, 1	1988-04-26
Method of in vitro fertilization Grant 4,589,402 - Hodgen , et al. May 20, 1	1986-05-20
Hydrocephalic antenatal vent for intrauterine treatment (HAVIT) Grant 4,413,985 - Wellner , et al. November 8, 1	1983-11-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.